German vaccine manufacturer BioNTech is to request the authorisation of its COVID-19 vaccine for children from the age of 12 in the European Union, it announced on Thursday.
The news magazine Der Spiegel had reported the request would be filed on Wednesday.
“We have submitted the study data for those aged 12 to 15 for approval in the United States; in Europe we are in the last steps,” BioNTech chief, Ugur Sahin, said according to Der Spiegel.
The approval process at EMA usually takes only a few weeks. (dpa/NAN)
Short Link: https://wp.me/pcj2iU-3ziv
- Nigeria’s Federal Capital Territory (FCT) Minister Pledges to Support Implementation of Polio Transition Plan to Preserve Legacy
- Gov. Sani-Bello advocates peaceful coexistence on Eid el-Fitr
- MINUSMA strongly condemns amputations of civilians in Gao region and calls for perpetrators to be brought to justice
- Buhari mourns Dogonyaro, former Chief of Defence Staff
- Coronavirus – Republic of South Africa: COVID-19 statistics in RSA as of May 12, 2021
- 16,000 jobs’ll be created when National Theatre’s renovation is completed – Official
- Gen. Joshua Dogonyaro, ex-CDS dies at 80 Death
- Coronavirus – Eritrea: Ministry of Health announcement (May 12, 2021)
- New board will run the National Theatre after renovations – GM